Form 4: MOH Director Ronna Romney Receives Stock Grant
Insider Transaction Report
Molina Healthcare Director Ronna Romney acquired 285 shares of common stock as part of her director compensation plan.
Summary
- Ronna Romney, a Director of Molina Healthcare, Inc. (MOH), acquired 285 shares of common stock on October 1, 2025.
- The acquisition was a grant of stock under the Issuer's 2025 Equity Incentive Plan, related to her services as a Director.
- The shares were granted at a price of $192.79 per share, which was the closing price of Molina Healthcare's common stock on the transaction date.
- The aggregate dollar value of the annual equity award for each director is set at $220,000, with one quarter, or $55,000, granted on the first day of each quarter.
- Following this transaction, Ronna Romney beneficially owns 17,416 shares, held indirectly by the Ronna Romney Revocable Trust.
Sentiment
Score: 6
Explanation: The filing reports a routine, expected stock grant to a director as part of compensation. This is generally neutral but slightly positive as it increases director ownership and aligns interests with shareholders, without indicating any significant operational or financial changes.
Positives
- The stock grant aligns the interests of Director Ronna Romney with those of shareholders, as her compensation includes equity in the company.
- The transaction is part of a pre-established, transparent director compensation plan, indicating good corporate governance practices.
Future Outlook
The filing indicates that the annual equity award for directors is structured with quarterly grants, suggesting similar grants will occur in future quarters as part of the 2025 Equity Incentive Plan.
Industry Context
Insider transactions, particularly routine stock grants to directors as part of their compensation, are common practice across publicly traded companies in the healthcare and other sectors. These grants are typically part of a broader compensation strategy designed to align management and director interests with long-term shareholder value.
Comparison to Industry Standards
- The practice of granting equity as part of director compensation is a standard corporate governance practice, aligning director incentives with company performance and shareholder interests.
- The structure of quarterly grants from an annual award is a common method for distributing equity compensation, similar to practices observed in many S&P 500 companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Reference | The transaction is explicitly linked to the Issuer's 2025 Equity Incentive Plan, which governs the grant of stock to directors for their services. | 2025-10-01 | Reinforces the company's established framework for director compensation and aligns director incentives with long-term company performance. |
Related Party Transactions
- The stock grant to Director Ronna Romney constitutes a related party transaction, as it is compensation provided by the company to a member of its board of directors.
Stakeholder Impact
- Shareholders: Increased director ownership may be viewed positively as it aligns director interests with shareholder value creation.
- Employees: No direct impact mentioned, but the existence of an equity incentive plan can be a positive signal for broader employee equity programs.
Next Steps
- Future quarterly equity grants to directors are expected to continue under the 2025 Equity Incentive Plan, based on the established compensation structure.
Key Dates
| Date | Description |
|---|---|
| 2011-02-16 | Date of execution for the Limited Power of Attorney granted to Jeff D. Barlow and Codruta Catanescu for Section 16(a) filings. |
| 2025-10-01 | Date of transaction where Ronna Romney acquired 285 shares of Molina Healthcare common stock. |
| 2025-10-02 | Date the Form 4 was signed by Jeff D. Barlow, by power of attorney for Ronna Romney. |
Recommendation
holdThis Form 4 reports a routine, pre-scheduled stock grant to a director as part of her compensation. Such a transaction is expected and does not typically signal a material change in the company's financial health, operational outlook, or strategic direction that would warrant a change in investment recommendation. It primarily serves to align director incentives with shareholder interests.
Keywords
Molina Healthcare, MOH, Ronna Romney, Director, Stock Grant, Insider Transaction, Equity Incentive Plan, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.